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Abstract 
The use of natural or bioinspired materials to develop edible electronic devices is a potentially 
disruptive technology that can boost point-of-care testing. The technology exploits devices 
which can be safely ingested, along with pills or even food, and operated from within the 
gastrointestinal tract. Ingestible electronics could potentially target a significant number of 
biomedical applications, both as therapeutic and diagnostic tool, and this technology may also 
impact the food industry, by providing ingestible or food-compatible electronic tags that can 
“smart” track goods and monitor their quality along the distribution chain. We hereby propose 
temporary tattoo-paper as a simple and versatile platform for the integration of electronics onto 
food and pharmaceutical capsules. In particular, we demonstrate the fabrication of all-printed 
Organic Field-Effect Transistors (OFETs) on untreated commercial tattoo-paper, and their 
subsequent transfer and operation on edible substrates with a complex non-planar geometry. 
 
Main text 
Point-of-care testing is defined as the administration of real-time medical diagnostic assays 
directly near the place of patient care. The driving notion behind point-of-care devices is to 
bring the test conveniently and immediately to the patient, increasing the likelihood that the 
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physician and the care team will receive the results quicker, thus allowing for rapid and more 
efficient clinical management decisions. Such scenario has been enabled by the development 
of portable, simple to use and easy to read medical equipment. With the development of edible 
devices that can be safely ingested by the patient, perform a test or release a drug and then 
transmit a feedback, the pervasiveness of point-of-care testing can be further enhanced. The 
cost-effective and mass-scale production of this technology could favor its adoption also in 
underdeveloped countries, where many health issues are still endemic within the population, 
thanks to costs reduction. Furthermore, the food industry may find important applications of 
this technology too, in tracking, identification or monitoring of food specimens during 
preparation, delivery and stocking.[1–3] Until now, a number of ingestible technologies have 
been proposed to semi-invasively perform relevant biomedical therapeutic or diagnostic tasks, 
including edible power sources and energy harvesters,[4–7] adherence monitoring devices,[8] 
controlled drug-release systems,[9–11] sensors,[12–14] and even food quality monitoring 
devices.[15,16] However, the electronic circuitry employed in all these works has so far been 
based exclusively on standard Si-based electronics, or other inorganic technologies, which are 
often sizeable and bulky, and necessarily require cumbersome and costly fabrication processes, 
thus hampering the diffusion of edible electronics. In particular, these are energy intensive 
fabrication techniques, hardly scalable, and non-ideal for the low-cost high-throughput 
realization of disposable, one-time-use edible electronics (particularly in food monitoring 
applications).  On the other hand, organic electronic materials hold great potential, thanks to 
the possibility of realizing electronics at low-cost, with accessible and easily up-scalable 
techniques.[17–20] Moreover, the ability of “soft” organic materials to provide new interaction 
paths between electronic devices and living tissues, as well as the possibility to chemically 
synthesize a plethora of different molecules and polymers, may result in a novel class of edible 
devices with improved mechanical properties and biocompatibility.[21,22] Nonetheless, despite 
their strong potential, very few examples of organic electronic devices have been specifically 
proposed for this kind of applications. Contributions to this field include a set of edible passive 
wireless antennas able to conform to different foods and monitor their degradation in time,[15] 
as well as current sources fabricated with edible materials whose performances are compatible 
with those of conventional power supplies currently adopted for Si-based ingestible 
devices.[5,23,7] The only example of OFET fabricated on edible substrates was demonstrated by 
Irimia-Vladu et al., obtained by physical vapor deposition of natural and nature-inspired 
materials directly onto surface-engineered hard-gelatine capsules and caramelized glucose.[1] 
Conversely, the use of commercial tattoo-paper for the integration of biocompatible active 
electronic devices on edible substrates opens new and exciting perspectives in the long-term 
vision of widely accessible personal care applications: it is compatible with cost-effective and 
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mass-manufacturing printing techniques,[24,25] and it provides a general and flexible platform 
for easy integration of the devices on many different types of objects, without any type of 
surface treatment prior to device fabrication or transfer. 
 
Temporary tattoo-paper (or decal transfer paper) consists of a submicrometric film of 
ethylcellulose (EC), a cellulose derivative, attached to a paper sheet by means of a sacrificial 
water-soluble starch/dextrin layer (Figure 1a). EC is an ingestible material that can be 
commonly found in drug formulations as a coating agent, tablet binder or filler, while it is used 
as emulsifier in the food industry.[26] By exploiting tattoo-paper, it is possible to easily and 
reliably transfer the submicrometric ethylcellulose layer onto many different items: the tattoo-
paper is soaked with water that dissolves the starch sacrificial layer, and it is then pressed onto 
the target object; finally, the paper sheet is peeled off to release the conformable, hundreds of 
nanometers thick EC layer. In this work, different sets of p-type and n-type OFETs were 
fabricated onto temporary tattoo-paper, where EC acted both as transferrable substrate and as 
gate dielectric layer of the OFETs. 
 
Figure 1. OFET structure and fabrication on tattoo-paper. (a) Scheme of the tattoo-paper stack: 
EC is attached to standard paper by a sacrificial water-soluble starch/dextrin layer (thicknesses 
not to scale). (b) Molecular structure of the semiconductors. (c) Process-flow of the OFET 
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fabrication on tattoo-paper. (d, e) Schematic representation of the final structure of the device 
before (d) and after (e) transfer. (f) Scanning electron microscope (SEM) image of a cross 
section, milled by focused ion beam (FIB), of the device on tattoo paper: it is possible to 
distinguish the layers composing the substrate, EC, starch/dextrin and paper, as well as the 
sintered AgNPs bottom and top contacts, and the dielectric EC layer. (g, h) Photograph of a set 
of silver electrodes transferred on to a pharmaceutical capsule (g) and on a strawberry (h). 
 
OFET electrodes were realized by inkjet-printing and subsequent sintering of a commercially 
available silver nanoparticle (AgNP) ink. While bulk silver is an established bioinert food 
garnish, with a Recommended Dietary Allowance (RDA) of 350 µgAg/day for a 70 kg person, 
the assumptions on the AgNP biocompatibility with the human body are based on previous 
works.[2,5,27] and on the fact that sintered nanoparticles create a continuous layer of material that 
hinders phagocytosis, which is a dominant mechanism for in vitro cytotoxicity. As additional 
arguments, the amount of material used for a single transistor is in the range of 4 µgAg, well 
below the suggested limits for human daily consumption even in the case of simple, small-scale 
of integration circuits.[28] 
 
Four different polymer semiconductors were used in our tests to demonstrate the versatility of 
the transfer procedure and the compatibility with both good hole and electron transporting 
materials, as required by robust complementary logic circuits.[19] A well-known and 
biocompatible material, poly(3-hexylthiophene) (P3HT),[29,30] was employed both as pristine 
polymer and in a semiconductor-insulator polymer blend configuration with polystyrene (PS), 
in order to enhance and stabilize the performances of the OFETs.[31] We also employed some 
recently developed, high-performance donor-acceptor copolymers, such as poly[2,5-bis(2-
decylnonadecyl) pyrrolo[3,4-c]pyrrole-1,4-(2H,5H)-dione-(E)-1,2-di(2,2′-bithiophen-
5yl)ethene] (29-DPP-TVT) for p-type devices and poly{[N,N′-bis(2-octyldodecyl)-
naphthalene-1,4,5,8-bis(dicarboximide)-2,6-diyl]-alt-5,5′-(2,2′-bithiophene)} (P(NDI2OD-
T2)) for n-type devices. These state-of-the-art materials have reported field-effect hole and 
electron mobilities exceeding 1 cm2V-1s-1 respectively, depending on the deposition 
technique.[32,33] While testing the tattoo-transfer methodology with high-performance donor-
acceptor co-polymers is a relevant choice to assess our approach, no account on the 
biocompatibility of 29-DPP-TVT and P(NDI2OD-T2) is currently available, to the best of our 
knowledge. In spite of the extremely low quantity of active material exploited for the fabrication 
of a single OFET (in the range of picograms, see Table S1), this poses an obvious question on 
the overall biocompatibility of the final devices, which we address with preliminary 
experiments in a dedicated section. 
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The device fabrication steps are sketched in Figure 1c. The silver source and drain electrodes 
are inkjet-printed and subsequently sintered directly on untreated tattoo-paper, forming a 
channel with a width (W) of  1000 µm and a length (L) of  50 µm. Likewise, the 
semiconductor is also inkjet-printed, and annealed to remove residual solvent from the film. A 
separate piece of tattoo-paper is then used to laminate a thin EC layer on the device, by 
exploiting the already mentioned transfer technique. This second EC layer effectively acts as 
gate dielectric, providing an average gate capacitance of approximately 5.5 nFcm-2 at 100 Hz 
(Figure S2), a value compatible with conventional low-k insulating polymers such as 
PMMA.[34] At the end of the fabrication process, as shown in Figure 1d, the resulting OFET 
has a staggered top-gate bottom-contact configuration, and lies on tattoo-paper ready for 
transfer. The latter is achieved by first soaking the entire sample into water to dissolve the starch 
sacrificial layer, and then by placing it onto the edible substrate and removing the paper. OFETs 
are transferred on two different types of substrates: a glass microscope slide, serving as a rigid 
and planar reference, and a pharmaceutical, hard-gelatine capsule bought in a local pharmacy. 
In order to remove the water in excess after the final transfer, without compromising the 
integrity of the capsules, all samples are left to dry overnight in vacuum at pressure not inferior 
to 10 mbar, as such level is currently compatible with commercial vacuum drying (vacuum 
oven) technology, largely employed in the food and pharmaceutical industry.[35] Overall, the 
fabrication procedure encompasses only the use of scalable printing techniques and the tattoo 
transfer process. 
 
Electrical characterization of the samples was performed before and after transfer on the target 
substrate, to verify, through the comparison of results, eventual effects on the electrical 
performances upon lamination. Each set of OFETs, i.e. samples intended for transfer on glass 
and on capsule separately, consisted in a number of devices ranging from 15 to 25 per 
semiconductor type, to allow for an appropriate evaluation of the transfer procedure robustness 
(see Table S2 and Table S3, reporting respectively the transfer yields and the statistics on device 
parameters, including average Vt, average and highest mobilities, average ON/OFF and 
maximum currents in saturation regime). 
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Figure 2. OFET and logic inverter electrical characterization. (a-d) Average transfer 
characteristic curves in saturation regime (Vds = -60 V) of OFETs before (black) and after the 
transfer on glass (red) and on a pharmaceutical capsule (blue), for the four different active 
layers: neat P3HT (a), P3HT:PS blend (1:1) (b), 29-DPP-TVT (c) and P(NDI2OD-2T) (d); 
shaded areas represent Standard Deviation. OFETs geometrical parameters: W ≈ 1000 µm and 
L ≈ 50 µm. (e, f) Dark-field microscope images of printed P3HT (e) and P3HT:PS (f) films on 
EC, with scale-bar corresponding to 50 µm. (g) Average saturation mobilities for the four 
different semiconductors, before and after transfer, where the boxes indicate Standard 
Deviation. (h) VTC and gain curve of complementary inverter fabricated with P3HT:PS and 
P(NDI2OD-2T), acquired before (black) and after transfer on a pharmaceutical capsule (blue); 
(i) Saturation transfer curves of sample n-type device before (black) and after transfer on glass 
(red), with green curve demonstrating partial recovery of initial device performance after 
annealing in inert atmosphere. 
 
In Figure 2, the average OFET saturation currents and their standard deviation, obtained before 
and after transfer, as a function of the gate-source voltage (Vgs), are presented for the four 
different active layers. Devices prepared with pristine P3HT after the transfer are subject to an 
evident increase of the off current and shift of the threshold voltage to positive values, with 
average hole mobilities stable around 10-4 cm2V-1s-1. As previously described in literature, this 
behaviour suggests that the transfer procedure, which exposes the devices to light, air and water, 
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produces a doping of the active layer, which is not effectively reversed by the vacuum 
treatment.[36] Several works have investigated the improved performances of polythiophene-
based semiconductors when blended with insulating polymers, highlighting their enhanced 
mechanical flexibility, the superior transport properties and environmental stability.[31,36] In 
order to improve the stability of our devices’ performances, P3HT was blended with PS in a 
1:1 weight ratio and deposited following the same procedure. Microscope images of the active 
layer inkjet-printed on EC (Figures 2e, 2f) show the difference in morphology of the pristine 
semiconductor compared to the P3HT:PS blend. The latter, differently from the homogeneity 
of the pristine P3HT film, presents the features typical of a phase-separated sea-island 
morphology, the darker area likely constituting a percolative semiconducting path through PS 
islands.[37] The positive impact of blending on the device performances is evinced by an average 
increase of hole mobility of almost two orders of magnitude, consistent with what obtained by 
Lu G. et al., who witnessed an enhanced crystalline order of P3HT when embedded in an inert 
matrix. The characteristic transfer curves appear more robust to the transfer procedure, 
especially in full-accumulation regime, with hole mobilities of approximately 7x10-3 cm2V-1s-1 
before as well as after transfer. The curves show only a modest variation in threshold voltage, 
particularly in the case of devices transferred on the pharmaceutical capsule, while those 
transferred on glass are mainly affected by an increase in the off current. Both of these effects 
are again to be ascribed to the undesired and uncontrolled doping of P3HT during the transfer 
procedure, although in this case the pre-transfer characteristics in the on state of the OFET are 
largely preserved as a consequence of semiconductor encapsulation in the insulating matrix. 
Further mechanisms that contribute to the performance integrity after transfer are possibly the 
vertical composition gradient of the blend which limits the off current levels, as well as the 
improved molecular packing of the semiconductor.[36]  
 
To verify that modifications in P3HT characteristic curves are an effect of ambient instability 
rather than of the transfer process, we fabricated a third set of devices using a more stable 
semiconductor. For the purpose we selected a diketopyrrolopyrrole based co-polymer, 29-DPP-
TVT, which thanks to the lower HOMO level, lying at -5.26 eV as reported by Yu H. et al.,[32] 
is inherently less prone to ambient oxidation. The impact of the transfer process on the 
performance of the devices is indeed rather limited for the 29-DPP-TVT case compared to the 
pristine P3HT one. The average mobility values are stable in the range of 0.1 cm2V-1s-1, with a 
modest decrease in the case of devices transferred on pharmaceutical capsule, and the threshold 
voltages do not vary significantly before and after transfer. 
 
     
8 
 
Conversely, the transfer process has an appreciable effect on n-type devices fabricated with 
P(NDI2OD-2T). Figure 2d demonstrates a marked positive shift of the threshold voltage as a 
consequence of the transfer, as well as a reduction of the average saturation mobility, from 
7x10-2 cm2V-1s-1 to approximately 7x10-3 cm2V-1s-1, and a less sharp turn on region. All of these 
effects are well in agreement with the degradation mechanisms proposed by Di Pietro et al., 
which are induced by oxygen and water impurities interacting, both reversibly and irreversibly, 
with the NDI section of the copolymer backbone.[38] Indeed, partial recovery of the OFETs 
performances was achieved on those devices transferred on glass and annealed in inert 
atmosphere for approximately two hours (Figure 2i). We thus identify the cause of the 
substandard performances in the presence of environmental impurities that are not effectively 
removed by the vacuum treatment alone. Similarly to the p-type case, the selection of an 
inherently more environmentally stable electron transporting material should produce 
unmodified characteristic curves upon transfer.  
 
Our experiments overall demonstrate the possibility to transfer both p- and n-type transistors 
thanks to a paper-based temporary tattoo, where the final performance of the transferred device 
is dominated by the intrinsic ambient stability of the adopted semiconductor. This result paves 
the way for the realization of robust complementary circuits: to this extent, we employed the 
same process to fabricate a complementary logic inverter. Figures 2g and 2h report the inverter 
voltage transfer curves (VTC) obtained using P3HT:PS and P(NDI2OD-2T) for the p-type and 
n-type devices, respectively, on both glass and pharmaceutical capsule (noise margins and gain 
values reported in Table S4). As previously described, the n-type device is subject to a decrease 
in average maximum current of about one order of magnitude. For this reason, the inverter was 
deliberately designed to appear unbalanced before the transfer, the n-type OFET having 
geometrical parameters equal to the p-type transistor (both W ≈ 1000 µm and L ≈ 50 µm), so to 
outperform it before the transfer and thus obtain a more balanced inverter after lamination. In 
all cases, from the VTC, we extracted average gain values ranging from 14 to 25. 
 
The good electronic performance of the transferred circuits is meaningful if the adopted 
semiconductors are compatible with ingestion. Such demonstration is a complex task that would 
eventually require clinical tests. To start preparing the ground for future trials, we evaluated the 
possible cytotoxicity of 29-DPP-TVT and P(NDI2OD-2T) by means of the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay. We performed MTT 
assays on HUTU-80 and CACO-2 cells after 1, 2, 3 and 4 days in vitro. The two cell lines were 
specifically chosen for their upper and lower intestine derivation, being respectively from 
human duodenum and epithelial colorectal adenocarcinoma, and thus providing first indications 
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on the impact of the organic semiconductors on the GI tissue (P(NDI2OD-2T) also tested with 
HEK-293 cell line, human embryonic kidney cells, see SI). The MTT used for the proliferation 
assay is reduced to formazan solely in living cells, the reduction depending on the cellular 
metabolic activity, hence stronger formazan optical absorption indicates progressively larger 
cell population. Figure 3a and 3b show the results of the MTT assay carried with both cell lines 
on the two different semiconducting films, demonstrating that cell proliferation is substantially 
unaffected by the presence of the semiconducting polymers, thus excluding biocompatibility 
issues of the materials at this stage.[39,40] In order to ensure that cellular morphology is not 
altered when cells adhere to the semiconducting polymers, both HUTU-80 and CACO-2 were 
stained with phalloidin conjugated to a fluorophore, which selectively binds to f-actin proteins 
in living cells, and analysed by fluorescence microscopy. Figure 3c shows that the two cell lines 
present the same cellular morphology when grown on either of the semiconducting polymers 
and the glass control substrate. It must be noted that this biocompatibility analyses do not 
however cover other complex physiologic reactions that could be triggered by the device at the 
tissue and organ levels, which will require dedicated studies. 
 
Figure 3. Cell proliferation assays on high-performance organic semiconductors. Optical 
absorption of formazan collected at 1, 2, 3 and 4 days in vitro (a, b) and inverted fluorescence 
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microscope images (c) reported for HUTU-80 and CACO-2 cell lines grown on 29-DPP-TVT, 
P(NDI2OD-2T) and on glass as control. Scale-bars in 3c correspond to 100 µm. Error bars in 
(a, b) correspond to Standard Error estimated on three samples. 
 
In conclusion, organic transistors composed mainly of ingestible materials, both p-type and n-
type, can be easily transferred on edible substrates by means of untreated commercial tattoo-
paper. This system constitutes a simple and versatile platform for the integration of fully printed 
organic circuitry on food and pharmaceutical drugs, and it relies on a transfer procedure that 
does not alter the integrity of the ingestible substrate. The robustness of the transfer is evaluated 
on a statistically relevant number of OFETs, employing one biocompatible polymer and two 
high-mobility co-polymer semiconductors. A preliminary degree of biocompatibility of the 
former two is here assessed for the first time by cell proliferation assays, performed with two 
different cell lines derived from human GI tissue.  
 
Future works will focus on improving the overall performance stability of the device and its 
active layer, as well as on an aggressive scaling of the driving voltages in order to support 
OFETs’ operation at power levels compatible with state-of-the-art edible batteries.  
Interestingly, much higher specific capacitance values have been achieved by Petriz et al. with 
a different, specifically engineered, cellulose-based material, hence suggesting that future 
developments of the tattoo-paper approach could in principle allow for low voltage operation 
of the OFETs.[41] The realization of such stable, low-voltage, low-cost, easily transferrable, 
biocompatible organic electronic devices will pave the way to the development of a new set of 
point-of-care testing systems, constituted by edible sensors able to effectively operate from 
within the GI tract. Ingestible electronic systems that can be degraded within the digestive tract 
are attractive with respect to passivated inorganic electronics, as they completely remove the 
possibility of accumulation in the human body, which may become an issue in case of severe 
pathologies. Inherent edibility may also enable the direct integration of electronic sensors into 
food in the form of embedded smart probes, following a perishable good along its entire lifespan 
and capable of alerting the consumer when alteration of the properties is taking place. 
Furthermore, being edibility an extreme case of ecocompatibility, the future development of 
such technology platform will at the same time favor the reduction of the environmental impact 
of large area and flexible electronics technologies at large. Overall, with our work we take the 
first step along a promising path and demonstrate that printed polymer electronics is a potential 
enabler of such an appealing future technology. 
 
Experimental Section  
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Materials: Commercial tattoo-paper (Tattoo 2.1) was acquired from The Magic Touch Ltd. and 
used without any cleaning or surface treatment. Semiconducting polymers regioregular P3HT 
(average Mn 54,000-75,000, electronic grade, 99.995% trace metals basis) and P(NDI2OD-2T) 
(Activink™ N2200) were purchased from respectively Sigma Aldrich and Flexterra Inc., and 
used as received. 29-DPP-TVT was synthesized according to a previously reported protocol.[24] 
Polystyrene (analytical standard, average Mw = 290,000, average Mn = 130,000) was acquired 
from Sigma Aldrich. Silver-nanoparticle ink (TEC-IJ-060) was purchased from InkTec. 1,2-
Dichlorobenzene (DCB, anhydrous, 99%) and Mesitylene (Mesy, 98%) were purchased from 
Sigma Aldrich and used as received. 
 
Sample Preparation and Transfer: P3HT, P3HT:PS (1:1 mass ratio) and 29-DPP-TVT were 
dissolved in DCB (P3HT and P3HT:PS at 8 mg/ml, 29-DPP-TVT at 5 mg/ml) by stirring the 
solution at ~100 °C for 12 h. These inks were regularly stirred at ~100 °C for 20 min before 
printing. P(NDI2OD-2T) was dissolved in Mesy (8 mg/ml) by stirring the solution overnight at 
room temperature. 
AgNP ink was inkjet-printed (Fujifilm Dimatix, DMP2831) directly on commercial-tattoo 
paper without any type of surface treatment or cleaning process, apart from nitrogen flushing 
to remove dust from the sample area. AgNP ink was sintered immediately after deposition at 
~125 °C for 10 minutes in air, to achieve a channel width W of 1000 µm and length L of 50 µm. 
The semiconductors were inkjet-printed directly on the contact and channel area with the 
DMP2831, and annealed at ~125 °C for 10 min in air. An additional piece of tattoo-paper was 
soaked in MilliQ water and deposited on top of the contacts and the active layer area to release 
the EC layer, thus constituting the gate dielectric of the devices; water in excess was removed 
by placing the sample at ~125 °C for 10 min in air. Subsequently, the AgNP ink was inkjet-
printed on the EC layer acting as gate dielectric and immediately sintered at ~125 °C for 10 min 
in air. The devices were then annealed in inert atmosphere at ~125 °C (nitrogen filled glovebox, 
O2 and H2O levels below 1 ppm) for 2 h (29-DPP-TVT) and 12 h (P3HT, P3HT:PS and 
P(NDI2OD-2T)). The complementary inverters were fabricated employing the same procedure 
as the individual devices. All inkjet-printing was performed with a Fujifilm Dimatix DMP2831 
printer. Transfer was performed by soaking the tattoo-paper substrate in MilliQ water and 
subsequent deposition on microscope glass slide and hard gelatin capsule. Water in excess was 
removed by placing samples in vacuum atmosphere at a minimum nominal pressure of 10 mbar 
(Edwards RV12 pump) for 12 h. 
Samples for cell viability tests were prepared using the same formulations of P3HT, 29-DPP-
TVT and P(NDI2OD-2T) used for inkjet-printing. OSCs were spin-coated on clean SiO2 
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microscope slides rinsed in an ultrasonication bath in deionized water, Acetone and 2-Propanol 
(10 min each). 
 
Film and Device Characterization: Dark-field microscope images of P3HT and P3HT:PS 
inkjet-printed films were taken in reflection mode with a Zeiss Axio Scope A1. 
FIB-milled cross sections and SEM imaging of OFET device on tattoo paper before transfer 
were obtained with a Dual Beam FIB/SEM Helios Nano-Lab 600i (FEI) equipped with a Field 
Emission source. Samples surface was prepared by depositing a thin Au film (t  20 nm) by 
means of a Q150R sputter coater (Quorum Technologies). FIB-assisted deposition of Pt (25 x 
2 x 1 µm3) was carried out on the area of interest before FIB-milling and polishing of cross-
section (Ga+ source, 30 kV acceleration voltage). SEM images of cross sections were obtained 
under a sample tilt angle of 52° and with accelerating voltage of 18 kV. In order to highlight 
the features SEM images were post-processed (colorized) with Adobe Photoshop CS4. 
Measurements of the OFETs characteristic curves and of the inverters VTC were performed in 
inert atmosphere (nitrogen filled glovebox, O2 and H2O levels below 1 ppm) by means of an 
Agilent B1500A Semiconductor Parameter Analyzer. Device parameters were extracted 
considering the characteristic equation for field-effect transistors operating in saturation: 
Ids=(WC’p/2L)µsat(Vgs-Vt)2, where Ids is the source-drain current, C’p is the capacitance per unit 
area (5.3 nF/cm2 at 100 Hz) of the EC dielectric layer (see Supplementary Information, Figure 
S2), µsat the carrier mobility in saturation regime, Vgs and Vt the gate-source voltage and the 
threshold voltage respectively. Transfer characteristic curves of p-type (n-type) devices in linear 
and saturation regimes were acquired at Vds = -5 V (Vds = 5 V) and Vds = -60 V (Vds = 60 V) 
respectively. Mobility values and threshold voltages were obtained by a linear fitting of the 
square-root of Ids, over a voltage range of approximately 20 V, between 40 V and 60 V. Due to 
the non-ideal features of the transfer characteristics (see Supplementary Information), such 
obtained mobilities and threshold voltages should be regarded as OFET device parameters 
rather than values related to intrinsic properties of the active layers. After transfer, a certain 
number of devices displayed a non-negligible gate-drain current in the linear regime; only 
OFETs with leakage current significantly lower than Ids (at least two orders of magnitude) were 
considered for the statistical evaluation.  
The recovery of the performances of n-type devices is obtained by annealing the transferred 
samples in inert atmosphere at ~125 °C for 2 hours (Figure 2i). 
EC capacitance per unit area was extracted in a two probes configuration with an Agilent 4294A 
Impedance Analyzer. Samples were fabricated by transferring a EC layer on a SiO2 substrate 
with an evaporated Cr-Au (Cr: 2 nm, Au: 50 nm) bottom electrode and an inkjet-printed AgNP 
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top electrode. Capacitors were annealed in inert atmosphere at ~125 °C for 12 h before the 
measurements. 
 
Cell Viability: In order to evaluate 29-DPP-TVT and P(NDI2OD-2T) biocompatibility, the 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma Aldrich) assay 
was performed with two different cell lines: HUTU-80 (from human duodenum 
adenocarcinoma) and CACO-2 (from human epithelial colorectal adenocarcinoma) (both 
acquired from American Type Culture Collection). 
Cells were cultured in cell culture flasks containing Dulbecco’s modified Eagle’s medium 
(DMEM) with 10% Fetal Bovine Serum (FBS), 100 μg ml-1 Streptomycin, 100 U ml-1 Penicillin 
and 100 U ml-1 L-Glutamine. Culture flasks were maintained in humidified atmosphere at 37 
°C with 5 % CO2. 
When at confluence, the cells were enzymatically dispersed using trypsin-EDTA and then 
plated on the different polymer substrates at a concentration of 10,000 cells cm-2. 
The proliferation was evaluated after 1, 2, 3 and 4 days in vitro. For each time point the medium 
was removed and replaced with RPMI without phenol red containing 0.5 mg ml-1 of MTT 
reagent. Cells were re-incubated at 37 °C for 3 h. Formazan salt produced by cells through 
reduction of MTT was then solubilized with 200 ml of ethanol and the absorbance was read at 
560 nm and 690 nm (using a microplate reader TECAN Spark10M). The proliferation cell rate 
was calculated as the difference in absorbed intensity at 560 nm and 690 nm.  
 
Immunofluorescence Staining: Cells grown on glass coverslips coated with 29-DPP-TVT and 
P(NDI2OD-2T) were washed twice with PBS and fixed for 15 min at RT in 4 % 
paraformaldehyde and 4 % sucrose in 0.12 M sodium phosphate buffer, pH 7.4. Fixed cells 
were pre-incubated for 20 min in gelatin dilution buffer (GDB: 0.02 M sodium phosphate 
buffer, pH 7.4, 0.45 M NaCl, 0.2% (w/v) gelatin) containing 0.3% (v/v) Triton X-100, and 
subsequently incubated with Phalloidin Alexa Fluor 488 conjugated in GDB for 1 h at RT and 
finally washed with PBS. The images were acquired with an inverted fluorescence microscope 
(Nikon Eclipse Ti-U/ Lumencor Spectra X). 
 
Acknowledgements 
The authors thank A. Luzio for the photographs of capsules and strawberries, A. D. 
Scaccabarozzi for discussions on the polymer semiconductor:insulator blend formulation, F. 
Fumagalli for the insights on vacuum technology, M. Garbugli, N. Piva, A. Luzio, G. Dell’Erba 
and M. R. Antognazza for useful discussions. M. C. acknowledges support by the European 
Research Council (ERC) under the European Union’s Horizon 2020 research and innovation 
     
14 
 
program ‘HEROIC’, grant agreement 638059. F. G. acknowledges financial support from Top 
Global University Project at Waseda University, Tokyo from MEXT Japan. 
 
References 
[1] M. Irimia-Vladu, P. A. Troshin, M. Reisinger, L. Shmygleva, Y. Kanbur, G. 
Schwabegger, M. Bodea, R. Schwödiauer, A. Mumyatov, J. W. Fergus, V. F. Razumov, 
H. Sitter, N. S. Sariciftci, S. Bauer, Adv. Funct. Mater. 2010, 20, 4069. 
[2] C. J. Bettinger, Trends Biotechnol. 2015, 33, 575. 
[3] L. M. Dumitru, M. Irimia-Vladu, N. S. Sariciftci, Compr. Anal. Chem. 2016, 74, 247. 
[4] P. Nadeau, D. El-Damak, D. Glettig, Y. L. Kong, S. Mo, C. Cleveland, L. Booth, N. 
Roxhed, R. Langer, A. P. Chandrakasan, G. Traverso, Nat. Biomed. Eng. 2017, 1, 22. 
[5] Y. J. Kim, S.-E. Chun, J. Whitacre, C. J. Bettinger, J. Mater. Chem. B 2013, 1, 3781. 
[6] L. Yin, X. Huang, H. Xu, Y. Zhang, J. Lam, J. Cheng, J. A. Rogers, Adv. Mater. 2014, 
26, 3879. 
[7] X. Wang, W. Xu, P. Chatterjee, C. Lv, J. Popovich, Z. Song, L. Dai, M. Y. S. Kalani, S. 
E. Haydel, H. Jiang, Adv. Mater. Technol. 2016, 1, 1600059. 
[8] H. Hafezi, T. L. Robertson, G. D. Moon, K.-Y. Au-Yeung, M. J. Zdeblick, G. M. Savage, 
IEEE Trans. Biomed. Eng. 2015, 62, 99. 
[9] P. J. van der Schaar, J. F. Dijksman, H. Broekhuizen-de Gast, J. Shimizu, N. van 
Lelyveld, H. Zou, V. Iordanov, C. Wanke, P. D. Siersema, Gastrointest. Endosc. 2013, 
78, 520. 
[10] G. Traverso, C. M. Schoellhammer, A. Schroeder, R. Maa, G. Y. Lauwers, B. E. Polat, 
D. G. Anderson, D. Blankschtein, R. Langer, J. Pharm. Sci. 2015, 104, 362. 
[11] E. Caffarel-Salvador, A. Abramson, R. Langer, G. Traverso, Curr. Opin. Pharmacol. 
2017, 36, 8. 
[12] G. Traverso, G. Ciccarelli, S. Schwartz, T. Hughes, T. Boettcher, R. Barman, R. Langer, 
A. Swiston, PLoS One 2015, 10, e0141666. 
[13] C. Dagdeviren, F. Javid, P. Joe, T. von Erlach, T. Bensel, Z. Wei, S. Saxton, C. 
Cleveland, L. Booth, S. McDonnell, J. Collins, A. Hayward, R. Langer, G. Traverso, 
Nat. Biomed. Eng. 2017, 1, 807. 
[14] G. Iddan, G. Meron, A. Glukhovsky, P. Swain, Nature 2000, 405, 417. 
[15] H. Tao, M. A. Brenckle, M. Yang, J. Zhang, M. Liu, S. M. Siebert, R. D. Averitt, M. S. 
Mannoor, M. C. McAlpine, J. A. Rogers, D. L. Kaplan, F. G. Omenetto, Adv. Mater. 
2012, 24, 1067. 
[16] Y. Dudnyk, E.-R. Janeček, J. Vaucher-Joset, F. Stellacci, Sensors Actuators B Chem. 
2017, DOI 10.1016/j.snb.2017.12.057. 
     
15 
 
[17] H. Klauk, Organic Electronics : Materials, Manufacturing and Applications, Wiley-
VCH, 2006. 
[18] H. Sirringhaus, T. Kawase, R. H. Friend, T. Shimoda, M. Inbasekaran, W. Wu, E. P. 
Woo, Science 2000, 290, 2123. 
[19] B. Crone, A. Dodabalapur, Y.-Y. Lin, R. W. Filas, Z. Bao, A. LaDuca, R. Sarpeshkar, 
H. E. Katz, W. Li, Nature 2000, 403, 521. 
[20] Z. Bao, Y. Feng, A. Dodabalapur, V. R. Raju, A. J. Lovinger, Chem. Mater. 1997, 9, 
1299. 
[21] G. G. Malliaras, Biochim. Biophys. Acta - Gen. Subj. 2013, 1830, 4286. 
[22] J. Rivnay, R. M. Owens, G. G. Malliaras, Chem. Mater. 2014, 26, 679. 
[23] Y. J. Kim, W. Wu, S.-E. Chun, J. F. Whitacre, C. J. Bettinger, Proc. Natl. Acad. Sci. U. 
S. A. 2013, 110, 20912. 
[24] J. R. Windmiller, A. J. Bandodkar, G. Valdés-Ramírez, S. Parkhomovsky, A. G. 
Martinez, J. Wang, Chem. Commun. 2012, 48, 6794. 
[25] A. Zucca, C. Cipriani, S. Sudha, S. Tarantino, D. Ricci, V. Mattoli, F. Greco, Adv. 
Healthc. Mater. 2015, 4, 983. 
[26] R. H. Dave, “Overview of pharmaceutical excipients used in tablets and capsules,” can 
be found under http://drugtopics.modernmedicine.com/drug-
topics/news/modernmedicine/modern-medicine-news/overview-pharmaceutical-
excipients-used-tablets, December 2017. 
[27] M. van der Zande, R. J. Vandebriel, E. Van Doren, E. Kramer, Z. Herrera Rivera, C. S. 
Serrano-Rojero, E. R. Gremmer, J. Mast, R. J. B. Peters, P. C. H. Hollman, P. J. M. 
Hendriksen, H. J. P. Marvin, A. A. C. M. Peijnenburg, H. Bouwmeester, ACS Nano 2012, 
6, 7427. 
[28] A. B. G. Lansdown, Adv. Pharmacol. Sci. 2010, 2010, 910686. 
[29] N. Martino, P. Feyen, M. Porro, C. Bossio, E. Zucchetti, D. Ghezzi, F. Benfenati, G. 
Lanzani, M. R. Antognazza, Sci. Rep. 2015, 5, 8911. 
[30] E. Zucchetti, M. Zangoli, I. Bargigia, C. Bossio, F. Di Maria, G. Barbarella, C. 
D’Andrea, G. Lanzani, M. R. Antognazza, J. Mater. Chem. B 2017, 2, 3. 
[31] A. D. Scaccabarozzi, N. Stingelin, J. Mater. Chem. A 2014, 2, 10818. 
[32] H. Yu, K. H. Park, I. Song, M.-J. Kim, Y.-H. Kim, J. H. Oh, J. Mater. Chem. C 2015, 3, 
11697. 
[33] S. G. Bucella, A. Luzio, E. Gann, L. Thomsen, C. R. McNeill, G. Pace, A. Perinot, Z. 
Chen, A. Facchetti, M. Caironi, Nat. Commun. 2015, 6, 8394. 
[34] J. Veres, S. Ogier, G. Lloyd, D. de Leeuw, 2004, DOI 10.1021/CM049598Q. 
[35] S. R. S. Dev, V. G. S. Raghavan, Dry. Technol. 2012, 30, 1147. 
     
16 
 
[36] G. Lu, J. Blakesley, S. Himmelberger, P. Pingel, J. Frisch, I. Lieberwirth, I. Salzmann, 
M. Oehzelt, R. Di Pietro, A. Salleo, N. Koch, D. Neher, Nat. Commun. 2013, 4, 1588. 
[37] M. E. Nicho, C. H. García-Escobar, M. C. Arenas, P. Altuzar-Coello, R. Cruz-Silva, M. 
Güizado-Rodríguez, Mater. Sci. Eng. B 2011, 176, 1393. 
[38] R. Di Pietro, D. Fazzi, T. B. Kehoe, H. Sirringhaus, J. Am. Chem. Soc. 2012, 134, 14877. 
[39] D. Gerlier, N. Thomasset, J. Immunol. Methods 1986, 94, 57. 
[40] T. Mosmann, J. Immunol. Methods 1983, 65, 55. 
[41] A. Petritz, A. Wolfberger, A. Fian, M. Irimia-Vladu, A. Haase, H. Gold, T. Rothländer, 
T. Griesser, B. Stadlober, Appl. Phys. Lett. 2013, 103, 153303. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
17 
 
Supporting Information  
 
 
Tattoo-Paper Transfer as a Versatile Platform for All-Printed Organic Edible 
Electronics 
 
Giorgio E. Bonacchini, Caterina Bossio, Francesco Greco, Virgilio Mattoli, Yun-Hi Kim, 
Guglielmo Lanzani*, Mario Caironi* 
 
 
 
Materials Dose [grams per device] 
P3HT 2.5 x 10-12 (pg) 
P(NDI2OD-T2) 2.5 x 10-12 (pg) 
29-DPP-TVT 1.6 x 10-12 (pg) 
P3HT:PS 2.5 x 10-12 (pg) 
Sintered AgNPs 4 x 10-6 (μg) 
Ethylcellulose 6.4 x 10-6 (μg) 
Table S1. Estimated amount of semiconducting and conductive material for each OFET in 
grams per device (units in brackets indicate order of magnitude). 
 
 
 
 
 
 
 
 
 
 
 
 
     
18 
 
 
Figure S1. SEM images of OFET on tattoo-paper, before transfer, and its cross section 
produced by FIB milling. Left, top:  top view: left, bottom: tilted view (α = 52˚) of milled cross 
section area. Right: high magnification tilted view of cross section with indications regarding 
the thickness of all the layers. 
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Figure S2. Top images report on EC capacitor structure, and on equivalent electrical circuit 
used to extract effective C’p from impedance data. Bode plots of characteristic device (bottom-
left) and average effective specific capacitance versus frequency (top-right) of EC. Shaded area 
represents standard deviation of average C’p, calculated from 7 devices.  
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 P3HT P3HT:PS 29-DPP-TVT P(NDI2OD-2T) 
Pre-transfer 42/50 47/50 47/50 39/41 
Transfer on glass 17/22 24/24 24/24 12/15 
Transfer on 
capsule 18/20 22/23 16/23 17/24 
Table S2. Number of devices working for each type of active material, before and after 
transfer on glass and on capsule. 
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  Pre-transfer µavg [cm2V-1s-1] µmax [cm2V-1s-1] Vt [V] ON/OFF Imax [A] 
P3HT (1.97±1.31)x10-4 5.90x10-4 -11.43 102 1.94x10-8 
P3HT:PS (7.09±3.29)x10-3 1.51x10-2 -18.10 >104 6.95x10-7 
29-DPP-TVT (1.46±0.81)x10-1 3.24x10-1 -28.61 104 8.31x10-6 
P(NDI2OD-2T) (7.83±2.87)x10-2 1.38x10-1 16.48 104 8.38x10-6 
      
 Transfer on glass 
 µavg [cm2V-1s-1] µmax [cm2V-1s-1] Vt [V] ON/OFF Imax [A] 
P3HT (1.97±1.12)x10-4 4.18x10-4 -1.16 102 3.82x10-8 
P3HT:PS (6.42±2.73)x10-3 1.09x10-2 -14.64 102 7.13x10-7 
29-DPP-TVT (1.53±0.73)x10-1 2.73x10-1 -30.04 104 7.97x10-6 
P(NDI2OD-2T) (6.54±2.59)x10-3 1.17x10-2 29.75 103 3.53x10-7 
      
 Transfer on capsule 
 µavg [cm2V-1s-1] µmax [cm2V-1s-1] Vt [V] ON/OFF Imax [A] 
P3HT (8.4±8.21)x10-5 3.03x10-4 46.90 10 2.68x10-8 
P3HT:PS (6.83±2.61)x10-3 1.07x10-2 -8.95 104 9.54x10-7 
29-DPP-TVT (8.70±0.50)x10-2 1.68x10-1 -29.48 104 4.77x10-6 
P(NDI2OD-2T) (2.16±1.10)x10-2 5.34x10-2 23.83 103 1.67x10-6 
Table S3. Statistics on device parameters at before and after the transfer process. 
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Figure S3. Sample OFET fabricated with P3HT and transferred on glass. Transfer curves (top-
left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  obtained 
with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves for the 
extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S4. Sample OFET fabricated with P3HT and transferred on capsule. Transfer curves 
(top-left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  
obtained with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S5. Sample OFET fabricated with P3HT:PS and transferred on glass. Transfer curves 
(top-left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  
obtained with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S6. Sample OFET fabricated with P3HT:PS and transferred on capsule. Transfer curves 
(top-left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  
obtained with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S7. Sample OFET fabricated with 29-DPP-TVT and transferred on glass. Transfer 
curves (top-left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  
obtained with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S8. Sample OFET fabricated with 29-DPP-TVT and transferred on capsule. Transfer 
curves (top-left) obtained with Vds,lin = -5 V and Vds,sat = -60 V. Output curves (top-right) curves  
obtained with Vgs steps of -10 V between 0 V and -60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S9. Sample OFET fabricated with P(NDI2OD-T2) and transferred on glass. Transfer 
curves (top-left) obtained with Vds,lin = 5 V and Vds,sat = 60 V. Output curves (top-right) curves  
obtained with Vgs steps of 10 V between 0 V and 60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
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Figure S10. Sample OFET fabricated with P(NDI2OD-T2) and transferred on capsule. Transfer 
curves (top-left) obtained with Vds,lin = 5 V and Vds,sat = 60 V. Output curves (top-right) curves  
obtained with Vgs steps of 10 V between 0 V and 60 V. Bottom images represent  curves 
for the extraction of mobility and threshold voltage, before (left) and after (right) transfer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Vdd [V] Vss [V] Vm [V]   Vil [V] Vol [V] Vih [V] Voh [V]   NMl [V] NMh [V] NMl [%] NMh [%]   Gain 
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Pre-transfer  
to glass 
60 0 14.5 
 
7 3.9 17.5 56.3 
 
3.1 38.8 10.3 129.3 
 
20 
Pre-transfer  
to capsule 
60 0 17 
 
11.5 3.7 20 56.3 
 
7.8 36.3 26 121 
 
25 
Transfer  
on glass 
60 0 38.5 
 
33.5 4 43.5 55.7 
 
29.5 12.2 93.3 40.7 
 
15 
Transfer  
on capsule 
60 0 37   32 4 41 56.2   28 15.2 93.3 50.7   25 
Table S4. Complementary inverter parameters, before and after the transfer. Definition of the 
parameters as in Sedra, A. S. & Smith, K. C. Microelectronic circuits, Oxford Univ. Press, 
Oxford, 1998. 
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Figure S11. Cell proliferation assay (MTT test) performed on P(NDI2OD-T2) with human 
embryonic kidney cells (HEK-293). Error bars represent Standard Error estimated on three 
samples. 
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Figure S12. Fluorescence microscope images reported for HEK-293 cell line grown on glass 
control (left) and P(NDI2OD-2T) (right). F-actin proteins appearing in green and nuclei in blu. 
Scale bar correspond to 100 µm. 
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Figure S13. Top graphs show the transfer curves in saturation regime of one p-type (a) and one 
n-type transistors (b) after approximately one year of storage in a N2 filled glovebox. In 
particular, Ids in saturation regime for a single 1-year-old OFET (blue) is compared with the 
average current (black, shaded area represents Standard Deviation) of approximately 15-20 
fresh devices. Bottom images show a set of electrodes transferred on a pharmaceutical capsule 
approximately 1 year before the pictures were taken. After one year the tattoo has not detached 
from the capsule, and it does not seem to delaminate upon mechanical deformation of the 
capsule. 
 
